ClinicalTrials.gg
CompletedNCT00422851Updated Nov 13, 2017

Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3c

An observational study in Healthy, sponsored by University of Pittsburgh. Completed at 1 site in United States. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-11-13.

Sponsored by University of Pittsburgh · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
45
Ages
18 Years to 50 Years
Sex
All
01

Study summary

This study will determine if gas can pass between the environment and the middle ear by way of the eardrum. This route of gas exchange was observed in animals but has not been studied in humans. If gas exchange across the eardrum is documented and the rate is sufficiently high, this can help explain certain past observations such as why middle ear pressure does not change very much in some children and adults when they have a cold or flu. The investigators also expect that the rate of gas exchange across the eardrum will depend on whether or not the eardrum has scarred or abnormally thin regions.

Read the detailed description

Middle-ear (ME) pressure is a measure of the number of contained gas moles, and processes that addd or remove gas moles from the relatively fixed volume ME cavity change its pressure. Experimental results from animal studies document significant gas exchange across the tympanic membrane and if confirmed for humans may explain some of the paradoxical findings for children with poor Eustachian tube function such as the preservation of an aerated ME when the normal routes of gas supply are disrupted. This study measures the rates of reactive and inert gas exchange across the adult tympanic membrane with and without structural abnormalities and determines if these transfers are purely diffusive phenomena. The resulting data will be used to develop species-specific rate-constants that will be used as parameters in modeling ME pressure regulation.

02

Conditions studied

  • Healthy

Browse trials for

Keywords

  • otitis
  • gas diffusion
  • Eustachian tube
  • tympanic membrane
03

In context

Otitis

247 studies on the registry are indexed under Otitis; 21 are open to participants now.

This study's enrollment of 45 is below the median of 140 across 63 observational studies indexed under Otitis.

Browse Otitis studies →

Lead sponsor

University of Pittsburgh is the lead sponsor of 1,414 studies on the registry; 168 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 4 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Adults 18-50 years old with at least one intact and effusion-free middle ear

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 18-50 years old
  • at least one intact and effusion-free middle ear

Exclusion criteria

Exclusion Criteria:

  • bilateral otitis media
  • unable to remain relaxed and quiet for up to 2 hours
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
45 participants

Groups and cohorts

  • 1

    Normal tympanic membrane

  • 2

    tympanosclerosis

  • 3

    dimeric (atrophic)

06

Study locations

1 site
  • ENT Research Center Children's Hospital of Pittsburgh
    Pittsburgh, Pennsylvania 15213, United States
07

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jun 2007 and a completion of Feb 2009. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 12, 2007
First posted
Jan 17, 2007
Start
Jun 2007
CompletionActual
Feb 2009
Last update
Nov 13, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 13, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00422851
Responsible party
J. Douglas Swarts (Associate Professor, University of Pittsburgh) — Principal investigator
First posted
Jan 17, 2007
Start date
Jun 2007
Completion
Feb 2009
Last update
Nov 13, 2017

Study contacts

William Doyle, PhD
principal investigator · University of Pittsburgh
J. Douglas Swarts, PhD
study director · University of Pittsburgh

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion